Kingsley Ibhazehiebo, Ph.D

Publications

For PubMed listings, click here

Ibhazehiebo K, Rho JM, Kurrasch DM. Metabolism-based drug discovery in zebrafish: an emerging strategy to uncover new anti-seizure therapies. Neuropharmacology, 176, 107988. 2020.

Ibhazehiebo, K., Gavrilovici, C., de la Hoz, C. L., Ma, S. C., Rehak, R., Kaushik, G., Meza Santoscoy, P.L., Scott, L., Nath, N., Kim, D.Y., Rho, J.M., & Kurrasch D.M. A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target. Brain, 141(3), 744-761. Jan 24, 2018.

*Best publication award to K Ibhazehiebo by Canadian League Against Epilepsy, 2018

Kinch, C. D., Ibhazehiebo, K., Jeong, J. H., Habibi, H. R., & Kurrasch, D. M. Low-dose exposure to bisphenol A and replacement bisphenol S induces precocious hypothalamic neurogenesis in embryonic zebrafish. Proceedings of the National Academy of Sciences, 112(5), 1475-1480. Feb 3, 2015.

Awards

•  Personally profiled in UCalgary’s Utoday magazine and UCalgary Medicine 2014, 2018
•  Canadian League Against Epilepsy (CLAE)Trainee publication award, 2018
•   Early Career Forum Travel Award from The Endocrine Society, 2018
•   Awarded a Canadian Institutes of Health Research (CIHR) Post-doctoral fellowship, 2012 – 2014
•   New Investigator`s award, Gunma University Graduate School of Medicine, 2011
•   Highest Award for excellent program, Gunma University Graduate School of Medicine, 2010
•   Dean`s Award for excellent research activity and presentation, Gunma University Graduate School of Medicine, 2008-2010
•   Young Investigator`s Award, 9th Asia and Oceania Thyroid Association Congress, 2009
•   Japan Student Service Association organization (JASSO) Scholarship, 2009
•   Awarded 12 prestigious travel awards , 2006 – 2018